Trogden K, Zhu X, Lee J, Wright C, Gu G, Kaverina I. Regulation of Glucose-Dependent Golgi-Derived Microtubules by cAMP/EPAC2 Promotes Secretory Vesicle Biogenesis in Pancreatic β Cells. Curr Biol. 2019;29:2339-2350.e5 pubmed publisher

Pang Y, Yamamoto H, Sakamoto H, Oku M, Mutungi J, Sahani M, et al. Evolution from covalent conjugation to non-covalent interaction in the ubiquitin-like ATG12 system. Nat Struct Mol Biol. 2019;: pubmed publisher

Schiavon C, Griffin M, Pirozzi M, Parashuraman R, Zhou W, Jinnah H, et al. Compositional complexity of rods and rings. Mol Biol Cell. 2018;29:2303-2316 pubmed publisher

Rother M, Gonzalez E, Teixeira da Costa A, Wask L, Gravenstein I, Pardo M, et al. Combined Human Genome-wide RNAi and Metabolite Analyses Identify IMPDH as a Host-Directed Target against Chlamydia Infection. Cell Host Microbe. 2018;23:661-671.e8 pubmed publisher

Zeng F, Hua Y, Liu X, Liu S, Lao K, Zhang Z, et al. Gpn2 and Rba50 Directly Participate in the Assembly of the Rpb3 Subcomplex in the Biogenesis of RNA Polymerase II. Mol Cell Biol. 2018;38: pubmed publisher

Kichko T, Kobal G, Reeh P. Cigarette smoke has sensory effects through nicotinic and TRPA1 but not TRPV1 receptors on the isolated mouse trachea and larynx. Am J Physiol Lung Cell Mol Physiol. 2015;309:L812-20 pubmed publisher

Choe K, Jang J, Park I, Kim Y, Ahn S, Park D, et al. Intravital imaging of intestinal lacteals unveils lipid drainage through contractility. J Clin Invest. 2015;125:4042-52 pubmed publisher

Ding Y, Shi W, Xie G, Yu A, Wang Q, Zhang Z. CX3CR1 Mediates Nicotine Withdrawal-Induced Hyperalgesia via Microglial P38 MAPK Signaling. Neurochem Res. 2015;40:2252-61 pubmed publisher

McElhinney C, O Kiely P, Elliott C, Danaher M. Development and validation of an UHPLC-MS/MS method for the determination of mycotoxins in grass silages. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32:2101-12 pubmed publisher

Alsharari S, King J, Nordman J, Muldoon P, Jackson A, Zhu A, et al. Effects of Menthol on Nicotine Pharmacokinetic, Pharmacology and Dependence in Mice. PLoS ONE. 2015;10:e0137070 pubmed publisher

Falconer S, Peagam W, Oniscu G. Early or Late Conversion From Tac-BD to Tac-BD in Renal Transplantation: When is the Right Time?. Transplant Proc. 2015;47:1741-5 pubmed publisher

Nassenstein C, Wiegand S, Lips K, Li G, Klein J, Kummer W. Cholinergic activation of the murine trachealis muscle via non-vesicular acetylcholine release involving low-affinity choline transporters. Int Immunopharmacol. 2015;29:173-80 pubmed publisher

Samengo I, Currò D, Martire M. Nicotinic receptors modulate the function of presynaptic AMPA receptors on glutamatergic nerve terminals in the trigeminal caudal nucleus. Neurochem Int. 2015;90:166-72 pubmed publisher

Tachibana S, Touhara K, Ejima A. Modification of Male Courtship Motivation by Olfactory Habituation via the GABAA Receptor in Drosophila melanogaster. PLoS ONE. 2015;10:e0135186 pubmed publisher

Hecker A, Küllmar M, Wilker S, Richter K, Zakrzewicz A, Atanasova S, et al. Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1β Release. J Immunol. 2015;195:2325-34 pubmed publisher

Keppeke G, Calise S, Chan E, Andrade L. Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction. J Genet Genomics. 2015;42:287-99 pubmed publisher

Fukami T, Kariya M, Kurokawa T, Iida A, Nakajima M. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases. Eur J Pharm Sci. 2015;78:47-53 pubmed publisher

Xie X, Jiang Y, Lai X, Xiang S, Shou Z, Chen J. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. BMC Nephrol. 2015;16:91 pubmed publisher

de Jonge H, Vanhove T, de Loor H, Verbeke K, Kuypers D. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. Br J Clin Pharmacol. 2015;80:548-59 pubmed publisher

Springer S, Yi K, Park J, Rajpurohit A, Price A, Lauring J. Engineering targeted chromosomal amplifications in human breast epithelial cells. Breast Cancer Res Treat. 2015;152:313-21 pubmed publisher

Drewry L, Sibley L. Toxoplasma Actin Is Required for Efficient Host Cell Invasion. MBio. 2015;6:e00557 pubmed publisher

Nagib A, Abbas M, Abu Elmagd M, Denewar A, Neamatalla A, Refaie A, et al. Long-term study of steroid avoidance in renal transplant patients: a single-center experience. Transplant Proc. 2015;47:1099-104 pubmed publisher

Oikawa S, Mano A, Iketani M, Kakinuma Y. Nicotinic receptor-dependent and -independent effects of galantamine, an acetylcholinesterase inhibitor, on the non-neuronal acetylcholine system in C2C12 cells. Int Immunopharmacol. 2015;29:31-5 pubmed publisher

Ibáñez Sandoval O, Xenias H, Tepper J, Koós T. Dopaminergic and cholinergic modulation of striatal tyrosine hydroxylase interneurons. Neuropharmacology. 2015;95:468-76 pubmed publisher

Liu S, Shao Z, Puche A, Wachowiak M, Rothermel M, Shipley M. Muscarinic receptors modulate dendrodendritic inhibitory synapses to sculpt glomerular output. J Neurosci. 2015;35:5680-92 pubmed publisher

Bonnet A, Bretes H, Palancade B. Nuclear pore components affect distinct stages of intron-containing gene expression. Nucleic Acids Res. 2015;43:4249-61 pubmed publisher

Yang Y, Tang Q, Zhao M, Liang G, Wu H, Li D, et al. The effect of mycophenolic acid on epigenetic modifications in lupus CD4+T cells. Clin Immunol. 2015;158:67-76 pubmed publisher

Fox B, Bzik D. Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection. Infect Immun. 2015;83:2148-55 pubmed publisher

Liu X, Sheng L, Zhao M, Mi J, Liu Z, Li Y. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates. Drug Metab Pharmacokinet. 2015;30:89-96 pubmed publisher

Li Y, Li G, Görling B, Luy B, Du J, Yan J. Integrative analysis of circadian transcriptome and metabolic network reveals the role of de novo purine synthesis in circadian control of cell cycle. PLoS Comput Biol. 2015;11:e1004086 pubmed publisher

Gao C, Shi R, Wang T, Tan H, Xu H, Ma Y. Interaction between oblongifolin C and UDP-glucuronosyltransferase isoforms in human liver and intestine microsomes. Xenobiotica. 2015;45:578-85 pubmed publisher

Margaillan G, Rouleau M, Fallon J, Caron P, Villeneuve L, Turcotte V, et al. Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues. Drug Metab Dispos. 2015;43:611-9 pubmed publisher

Daniels C, Watterson E, Garcia R, Mazur G, Brackney R, Sanabria F. Revisiting the effect of nicotine on interval timing. Behav Brain Res. 2015;283:238-50 pubmed publisher

Pauly M, Lauring A. Effective lethal mutagenesis of influenza virus by three nucleoside analogs. J Virol. 2015;89:3584-97 pubmed publisher

Hedrick T, Waters J. Acetylcholine excites neocortical pyramidal neurons via nicotinic receptors. J Neurophysiol. 2015;113:2195-209 pubmed publisher

COTTON D. Celebrating the ACP centennial: from the Annals archive. Ann Intern Med. 2015;162:70 pubmed publisher

Silveira M, Malcolm E, Shoaib M, Winstanley C. Scopolamine and amphetamine produce similar decision-making deficits on a rat gambling task via independent pathways. Behav Brain Res. 2015;281:86-95 pubmed publisher

Evans A, Loeb K, Shulman H, Hassan S, Qiu W, Hockenbery D, et al. Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases. Am J Surg Pathol. 2015;39:212-20 pubmed publisher

Saika F, Kiguchi N, Kobayashi Y, Kishioka S. Peripheral alpha4beta2 nicotinic acetylcholine receptor signalling attenuates tactile allodynia and thermal hyperalgesia after nerve injury in mice. Acta Physiol (Oxf). 2015;213:462-71 pubmed publisher

Wollmann G, Paglino J, Maloney P, Ahmadi S, van den Pol A. Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector. Virology. 2015;475:1-14 pubmed publisher

Han S, Hu L, Quach T, Simpson J, Trevaskis N, Porter C. Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug. Pharm Res. 2015;32:1830-44 pubmed publisher

Benck U, Banas B, Birck R. [Primary and secondary glomerular diseases]. Dtsch Med Wochenschr. 2014;139:2520-2 pubmed publisher

. Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis. Ann Intern Med. 2015;162:I24 pubmed publisher

Liu Z, Zhang H, Liu Z, Xing C, Fu P, Ni Z, et al. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Ann Intern Med. 2015;162:18-26 pubmed publisher

Hamilton B, Rybicki L, Dean R, Majhail N, Haddad H, Abounader D, et al. Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation. Am J Hematol. 2015;90:144-8 pubmed publisher

Finkin Groner E, Moradov D, Shifrin H, Bejar C, Nudelman A, Weinstock M. Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS. Br J Pharmacol. 2015;172:1101-13 pubmed publisher

Aboul Fotouh S. Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters. Psychopharmacology (Berl). 2015;232:1095-105 pubmed publisher

Carocci M, Hinshaw S, Rodgers M, Villareal V, Burri D, Pilankatta R, et al. The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication. Antimicrob Agents Chemother. 2015;59:85-95 pubmed publisher

Yang L, Zhao Z, Deng Y, Zhou Z, Hou J. Toxicity induced by F. poae-contaminated feed and the protective effect of Montmorillonite supplementation in broilers. Food Chem Toxicol. 2014;74:120-30 pubmed publisher

Muldoon P, Chen J, Harenza J, Abdullah R, Sim Selley L, Cravatt B, et al. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal. Br J Pharmacol. 2015;172:869-82 pubmed publisher

Goldberg N, Lyu T, Moshier E, Godbold J, Jabs D. Success with single-agent immunosuppression for multifocal choroidopathies. Am J Ophthalmol. 2014;158:1310-7 pubmed publisher

Bernardi R, Spanagel R. A two-injection protocol for nicotine sensitization. Behav Brain Res. 2014;275:11-4 pubmed publisher

Ray R, Rai S, Katyal A. Cholinergic receptor blockade by scopolamine and mecamylamine exacerbates global cerebral ischemia induced memory dysfunction in C57BL/6J mice. Nitric Oxide. 2014;43:62-73 pubmed publisher

Kang S, Shields A, Jupatanakul N, Dimopoulos G. Suppressing dengue-2 infection by chemical inhibition of Aedes aegypti host factors. PLoS Negl Trop Dis. 2014;8:e3084 pubmed publisher

Stevens R, Foster K, Miles C, Lane J, Kalil A, Florescu D, et al. A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation. 2015;99:197-209 pubmed publisher

Doycheva D, Jagle H, Zierhut M, Deuter C, Blumenstock G, Schiefer U, et al. Mycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-up. Br J Ophthalmol. 2015;99:87-91 pubmed publisher

Sommansson A, Wan Saudi W, Nylander O, Sjöblom M. The ethanol-induced stimulation of rat duodenal mucosal bicarbonate secretion in vivo is critically dependent on luminal Cl-. PLoS ONE. 2014;9:e102654 pubmed publisher

Delekta P, Dobry C, Sindac J, Barraza S, Blakely P, Xiang J, et al. Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo. J Virol. 2014;88:11199-214 pubmed publisher

Laws P, Kingston T, Walsh S, Shear N. Cytomegalovirus retinitis: a rare but preventable cause of blindness in dermatology patients. J Cutan Med Surg. 2014;18:287-90 pubmed

Oh C, Huh K, Ha J, Kim Y, Kim Y, Kim Y. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients. Transplantation. 2015;99:180-6 pubmed publisher

Ceppi F, Duval M, Teira P, Therrien R, Ovetchkine P, Mallette B, et al. Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymp. J Pediatr Hematol Oncol. 2014;36:e319-21 pubmed publisher

Raszewski G, Lemieszek M, Łukawski K, Juszczak M, Rzeski W. Chlorpyrifos and cypermethrin induce apoptosis in human neuroblastoma cell line SH-SY5Y. Basic Clin Pharmacol Toxicol. 2015;116:158-67 pubmed publisher

Lutz J, Kulshrestha M, Rogers D, Littleton J. A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia. Fitoterapia. 2014;98:11-21 pubmed publisher

Daher Abdi Z, Premaud A, Essig M, Alain S, Munteanu E, Garnier F, et al. Exposure to mycophenolic acid better predicts immunosuppressive efficacy than exposure to calcineurin inhibitors in renal transplant patients. Clin Pharmacol Ther. 2014;96:508-15 pubmed publisher

Kruk Słomka M, Michalak A, Budzynska B, Biała G. A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice. Pharmacol Rep. 2014;66:638-46 pubmed publisher

Azar L, Springer J, Langford C, Hoffman G. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study. Arthritis Rheumatol. 2014;66:2862-70 pubmed publisher

Ram R, Herscovici C, Dahan D, Israeli M, Dreyer J, Peck A, et al. Tailoring the GVHD prophylaxis regimen according to transplantation associated toxicities-Substituting the 3rd dose of methotrexate to mycophenolate mofetil. Leuk Res. 2014;38:913-7 pubmed publisher

Rathinam S, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, et al. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014;121:1863-70 pubmed publisher

Bagdas D, Muldoon P, Zhu A, Tyndale R, Damaj M. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice. Neuropharmacology. 2014;85:67-72 pubmed publisher

Carcoba L, Orfila J, Natividad L, Torres O, Pipkin J, Ferree P, et al. Cholinergic transmission during nicotine withdrawal is influenced by age and pre-exposure to nicotine: implications for teenage smoking. Dev Neurosci. 2014;36:347-55 pubmed publisher

Deckmann K, Filipski K, Krasteva Christ G, Fronius M, Althaus M, Rafiq A, et al. Bitter triggers acetylcholine release from polymodal urethral chemosensory cells and bladder reflexes. Proc Natl Acad Sci U S A. 2014;111:8287-92 pubmed publisher

Antonyan A, Pena Robichaux V, McHargue C. Orofacial granulomatosis successfully treated with mycophenolate mofetil. J Am Acad Dermatol. 2014;70:e137-9 pubmed publisher

Gujadhur A, Thomson N, Aung A, McLean C, Menahem S. CMV sinusitis in a HIV-negative renal transplant recipient. Transplantation. 2014;97:e55-7 pubmed publisher

Al Maimouni H, Gladman D, Ibanez D, Urowitz M. Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes. Arthritis Care Res (Hoboken). 2014;66:1905-9 pubmed publisher

Sidbury R, Davis D, Cohen D, Cordoro K, Berger T, Bergman J, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327-49 pubmed publisher

Gawel K, Labuz K, Jenda M, Silberring J, Kotlinska J. Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats. Behav Brain Res. 2014;268:169-76 pubmed publisher

White S, Carter C, Magoski N. A potentially novel nicotinic receptor in Aplysia neuroendocrine cells. J Neurophysiol. 2014;112:446-62 pubmed publisher

Tramsen L, Schmidt S, Roeger F, Schubert R, Salzmann Manrique E, Latge J, et al. Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells. Infect Immun. 2014;82:2649-56 pubmed publisher

Braida D, Ponzoni L, Martucci R, Sala M. A new model to study visual attention in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry. 2014;55:80-6 pubmed publisher

Derniame S, Lee F, Domogala A, Madrigal A, Saudemont A. Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxis. Transplantation. 2014;97:870-8 pubmed publisher

Kimura Y, Fujimura C, Ito Y, Takahashi T, Aiba S. Evaluation of the Multi-ImmunoTox Assay composed of 3 human cytokine reporter cells by examining immunological effects of drugs. Toxicol In Vitro. 2014;28:759-68 pubmed publisher

Rostas S, Kim M, Gabardi S. Risk evaluation and mitigation strategies: a focus on the mycophenolic acid preparations. Prog Transplant. 2014;24:33-6 pubmed publisher

Saayman S, Ackley A, Turner A, Famiglietti M, Bosque A, Clemson M, et al. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Mol Ther. 2014;22:1164-1175 pubmed publisher

Tsapepas D, McKeen J, Martin S, Walker McDermott J, Yang A, Hirsch J, et al. Risk evaluation and mitigation strategy programs in solid organ transplantation: the promises of information technology. J Am Med Inform Assoc. 2014;21:e358-62 pubmed publisher

Joy M, Roberts B, Wang J, Hu Y, Hogan S, Falk R. A pilot study of leukocyte expression patterns for drug metabolizing enzyme and transporter transcripts in autoimmune glomerulonephritis. Int J Clin Pharmacol Ther. 2014;52:303-13 pubmed publisher

Roodnat J, Hilbrands L, Hene R, de Sévaux R, Smak Gregoor P, Kal van Gestel J, et al. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation. Transplantation. 2014;98:47-53 pubmed publisher

Qasim M, Rahman H, Ahmed R, Oellerich M, Asif A. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions. Exp Cell Res. 2014;322:277-89 pubmed publisher

Lipson E, Bodell M, Kraus E, Sharfman W. Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma. J Clin Oncol. 2014;32:e69-71 pubmed publisher

El Sheikh A, Koenderink J, Wouterse A, Van den Broek P, Verweij V, Masereeuw R, et al. Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. Transl Res. 2014;164:46-56 pubmed publisher

Pauwels S, Peersman N, Gerits M, Desmet K, Vermeersch P. Response factor-based quantification for mycophenolic acid. Clin Chem. 2014;60:692-4 pubmed publisher

Hazlewood G, Metzler C, Tomlinson G, Gross W, Feldman B, Guillevin L, et al. Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis. Joint Bone Spine. 2014;81:337-41 pubmed publisher

Maneiro J, Lopez Canoa N, Salgado E, Gomez Reino J. Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis. Rheumatology (Oxford). 2014;53:834-8 pubmed publisher

Melancon K, Mulgaonkar S, Delcoro C, Wiland A, McCague K, Shihab F. Outcomes in ethnic minority renal transplant recipients receiving everolimus versus mycophenolate: comparative risk assessment results from a pooled analysis. Transplantation. 2013;96:1073-81 pubmed publisher

Bose B, Silverman E, Bargman J. Ten common mistakes in the management of lupus nephritis. Am J Kidney Dis. 2014;63:667-76 pubmed publisher

Langford C, Monach P, Specks U, Seo P, Cuthbertson D, McAlear C, et al. An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's). Ann Rheum Dis. 2014;73:1376-9 pubmed publisher

Leeaphorn N, Stokes M, Ungprasert P, LeCates W. Idiopathic granulomatous interstitial nephritis responsive to mycophenolate mofetil therapy. Am J Kidney Dis. 2014;63:696-9 pubmed publisher

Unal S, Sağ E, Kuskonmaz B, Kesici S, Bayrakci B, Ayvaz D, et al. Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab. Pediatr Blood Cancer. 2014;61:928-30 pubmed publisher

Chaigne B, Gatault P, Darrouzain F, Barbet C, Degenne D, Francois M, et al. Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study. Clin Exp Immunol. 2014;176:172-9 pubmed publisher

Hancock W. Effects of histone deacetylase inhibitors on alloresponses. Lancet Oncol. 2014;15:10-1 pubmed publisher

Choi S, Braun T, Chang L, Ferrara J, Pawarode A, Magenau J, et al. Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial. Lancet Oncol. 2014;15:87-95 pubmed publisher

Hogan J, Mohan P, Appel G. Diagnostic tests and treatment options in glomerular disease: 2014 update. Am J Kidney Dis. 2014;63:656-66 pubmed publisher

Lamba V, Sangkuhl K, Sanghavi K, Fish A, Altman R, Klein T. PharmGKB summary: mycophenolic acid pathway. Pharmacogenet Genomics. 2014;24:73-9 pubmed publisher

Lake J, Tusheva O, Graham B, Heuckeroth R. Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis. J Clin Invest. 2013;123:4875-87 pubmed

Hugh J, Van Voorhees A, Nijhawan R, Bagel J, Lebwohl M, Blauvelt A, et al. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J Am Acad Dermatol. 2014;70:168-77 pubmed publisher

Gorgan M, Bockorny B, Lawlor M, Volpe J, Fiel Gan M. Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. Arch Pathol Lab Med. 2013;137:1684-7 pubmed publisher

Demmers M, Baan C, Janssen M, Litjens N, Ijzermans J, Betjes M, et al. Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus. Transplantation. 2014;97:47-55 pubmed publisher

Hrehoret D, Alexandrescu S, Brasoveanu V, Grigorie R, Zielinski C, Popescu I. Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report. Chirurgia (Bucur). 2013;108:719-24 pubmed

Condon M. Response to 'Are steroids required for induction therapy and relapses in lupus nephritis?' by Abud-Mendoza et al. Ann Rheum Dis. 2013;72:e30 pubmed publisher

Adeli A, Drubach D, Machulda M. Resolution of neuropsychological and FDG-PET abnormalities in a patient with neuropsychiatric systemic lupus erythematosus. Cogn Behav Neurol. 2013;26:161-6 pubmed publisher

Star K, Ho V, Wang H, Odze R. Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis. Am J Surg Pathol. 2013;37:1319-28 pubmed publisher

Feuerstein J, Feuerstien J, Najarian R, Cheifetz A. Hickam's dictum in a patient with diarrhea. Gastroenterology. 2013;145:942, 1165 pubmed publisher

Champagne T, Walsh S. Mycophenolic acid for lymphomatoid papulosis. J Cutan Med Surg. 2013;17:332-4 pubmed

Welberry Smith M, Cherukuri A, Newstead C, Lewington A, Ahmad N, Menon K, et al. Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial. Transplantation. 2013;96:1082-8 pubmed publisher

Tedeschi B, Arnaud L, Hié M, Mathian A, Amoura Z. Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen. Ann Rheum Dis. 2014;73:474-5 pubmed publisher

Skardelly M, Glien A, Groba C, Schlichting N, Kamprad M, Meixensberger J, et al. The influence of immunosuppressive drugs on neural stem/progenitor cell fate in vitro. Exp Cell Res. 2013;319:3170-81 pubmed publisher

Iyengar S, Ebb D, Yuan Q, Shailam R, Bhan A. Case records of the Massachusetts General Hospital. Case 27-2013. A 6.5-month-old boy with fever, rash, and cytopenias. N Engl J Med. 2013;369:853-63 pubmed publisher

Abud Mendoza C, Gonzalez Amaro R. Are steroids required for induction therapy and relapses in lupus nephritis?. Ann Rheum Dis. 2013;72:e29 pubmed publisher

Bemer M, Sorror M, Sandmaier B, O Donnell P, McCune J. A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients. Cancer Chemother Pharmacol. 2013;72:607-18 pubmed publisher

Ciancio G, Sageshima J, Akpinar E, Gaynor J, Chen L, Zarak A, et al. A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. Transplantation. 2013;96:800-6 pubmed publisher

Yates C, Fourlanos S, Colman P, Cohney S. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin. Transplantation. 2013;96:726-31 pubmed publisher

Chen T, Fine D. Top 10 developments in lupus nephritis. Curr Rheumatol Rep. 2013;15:358 pubmed publisher

Anders H. [Standards and perspectives in the treatment of lupus nephritis]. Dtsch Med Wochenschr. 2013;138:1582-4 pubmed publisher

Levitsky J, Miller J, Huang X, Chandrasekaran D, Chen L, Mathew J. Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans. Transplantation. 2013;96:689-96 pubmed publisher

Cohen A, Treweek J, Edwards S, Leão R, Schulteis G, Koob G, et al. Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats. Addict Biol. 2015;20:56-68 pubmed publisher

Hilbrands R, Gillard P, van der Torren C, Ling Z, Verheyden S, Jacobs Tulleneers Thevissen D, et al. Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts. Transplantation. 2013;96:162-9 pubmed publisher

Chen H, Ye L, Su J, Li Y, Zeng J, Huo W. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013;27:35-8 pubmed

Prud homme G, Glinka Y, Hasilo C, Paraskevas S, Li X, Wang Q. GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone. Transplantation. 2013;96:616-23 pubmed publisher

Almugairen N, Hospital V, Bedane C, Duvert Lehembre S, Picard D, Tronquoy A, et al. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids. J Am Acad Dermatol. 2013;69:583-8 pubmed publisher

Li J, Kelly R. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent. J Am Acad Dermatol. 2013;69:565-9 pubmed publisher

McCormack F, Wilmott C, Young L, Wikenheiser Brokamp K. An atoll variant that mocks. Am J Respir Crit Care Med. 2013;188:110 pubmed publisher

Borni Duval C, Caillard S, Olagne J, Perrin P, Braun Parvez L, Heibel F, et al. Risk factors for BK virus infection in the era of therapeutic drug monitoring. Transplantation. 2013;95:1498-505 pubmed publisher

Condon M, Ashby D, Pepper R, Cook H, Levy J, Griffith M, et al. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis. 2013;72:1280-6 pubmed publisher

Mourer J, de Koning E, van Zwet E, Mallat M, Rabelink T, de Fijter J. Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients. Transplantation. 2013;96:49-57 pubmed publisher

Alba M, Flores Suarez L. Seven clinical conundrums in the treatment of ANCA-associated vasculitis. Clin Exp Rheumatol. 2013;31:S74-83 pubmed

Atlani M, Sharma R, Gupta A. Basiliximab induction in renal transplantation: long-term outcome. Saudi J Kidney Dis Transpl. 2013;24:473-9 pubmed

Mori Y, Ihara K, Yamaguchi W, Fujii T, Toda T, Nagata M, et al. [A case of combination therapy with MMF and steroids for idiopathic membranoproliferative glomerulonephritis]. Nihon Jinzo Gakkai Shi. 2013;55:177-84 pubmed

de Wispelaere M, Lacroix A, Yang P. The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase. J Virol. 2013;87:7367-81 pubmed publisher

Nadal M, Lococo B, Fazzini M, Gonzalez G, Otero A, Malvar A. Use of enteric coated mycophenolate sodium in adult resistant nephrotic syndrome. Clin Nephrol. 2013;79:439-44 pubmed publisher

Arns W, Sommerer C, Glander P, Ariatabar T, Porstner M, May C, et al. A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year. Clin Nephrol. 2013;79:421-31 pubmed publisher

Hogan J, Bomback A. Mycophenolate mofetil in severe lupus nephritis: should post hoc analyses change treatment patterns?. Am J Kidney Dis. 2013;61:692-3 pubmed publisher

Selden N, Al Uzri A, Huhn S, Koch T, Sikora D, Nguyen Driver M, et al. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. J Neurosurg Pediatr. 2013;11:643-52 pubmed publisher

Lee S, Park K, Park S, Kim J, Hong S, Lee S, et al. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice. Arthritis Rheum. 2013;65:1902-12 pubmed publisher

Wofsy D, Hillson J, Diamond B. Comparison of alternative primary outcome measures for use in lupus nephritis clinical trials. Arthritis Rheum. 2013;65:1586-91 pubmed publisher

Jakes A, Roy A, Veerasamy M, Bhandari S. Case report: Crohn's-like mycophenolate-induced colitis, a fallout in steroid-free regimens. Transplant Proc. 2013;45:842-4 pubmed publisher

Kieslichova E, Rocen M, Merta D, Kudla M, Splichal I, Cap J, et al. The effect of immunosuppression on manifestations of sepsis in an animal model of cecal ligation and puncture. Transplant Proc. 2013;45:770-7 pubmed publisher

Park H, Kang M, Kang Y, Chung S, Lee S, Park Y, et al. Two cases of refractory thrombocytopenia in systemic lupus erythematosus that responded to intravenous low-dose cyclophosphamide. J Korean Med Sci. 2013;28:472-5 pubmed publisher

Hoffman G. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?. Presse Med. 2013;42:643-50 pubmed publisher

Pipitone N, Salvarani C. CD25 blockade for refractory polymyositis. Clin Exp Rheumatol. 2013;31:474 pubmed

Fuyama M, Ikeda H, Isoyama K. [A case of focal segmental glomerulosclerosis with nephrotic syndrome after hematopoietic stem cell transplantatation for aplastic anemia]. Nihon Jinzo Gakkai Shi. 2013;55:83-9 pubmed

Look M, Stern E, Wang Q, DiPlacido L, Kashgarian M, Craft J, et al. Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice. J Clin Invest. 2013;123:1741-9 pubmed

Monach P. L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's). Presse Med. 2013;42:575-6 pubmed publisher

Ponticelli C, Graziani G. Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults. Expert Rev Clin Immunol. 2013;9:251-61 pubmed publisher

Tornatore K, Sudchada P, Attwood K, Wilding G, Gundroo A, DiFrancesco R, et al. Race and drug formulation influence on mycophenolic acid pharmacokinetics in stable renal transplant recipients. J Clin Pharmacol. 2013;53:285-93 pubmed publisher

Cervantes Castañeda R, Gonzalez Gonzalez L, Cordero Coma M, Yilmaz T, Foster C. Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up. Br J Ophthalmol. 2013;97:637-43 pubmed publisher

Guethoff S, Meiser B, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, et al. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. Transplantation. 2013;95:629-34 pubmed publisher

Gabardi S, Olyaei A. Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitors. Ann Pharmacother. 2012;46:1054-64 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Yang N, Wang Q, Wang W, Wang J, Li F, Tan S, et al. The design, synthesis and in vitro immunosuppressive evaluation of novel isobenzofuran derivatives. Bioorg Med Chem Lett. 2012;22:53-6 pubmed publisher

Staatz C, Tett S. Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?. Clin Pharmacokinet. 2011;50:759-72 pubmed publisher

Carta A, Briguglio I, Piras S, Corona P, Boatto G, Nieddu M, et al. Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors. Bioorg Med Chem. 2011;19:7070-84 pubmed publisher

Bolin P, Gohh R, Kandaswamy R, Shihab F, Wiland A, Akhlaghi F, et al. Mycophenolic acid in kidney transplant patients with diabetes mellitus: does the formulation matter?. Transplant Rev (Orlando). 2011;25:117-23 pubmed publisher

Tönshoff B, David Neto E, Ettenger R, Filler G, van Gelder T, Goebel J, et al. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation. Transplant Rev (Orlando). 2011;25:78-89 pubmed publisher

Felczak K, Chen L, Wilson D, Williams J, Vince R, Petrelli R, et al. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain. Bioorg Med Chem. 2011;19:1594-605 pubmed publisher

Sherwin C, Fukuda T, Brunner H, Goebel J, Vinks A. The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease. Clin Pharmacokinet. 2011;50:1-24 pubmed publisher

Mitsuhashi S, Takenaka J, Iwamori K, Nakajima N, Ubukata M. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives. Bioorg Med Chem. 2010;18:8106-11 pubmed publisher

Puri N, Prakash O, Manoharlal R, Sharma M, Ghosh I, Prasad R. Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans. Eur J Med Chem. 2010;45:4813-26 pubmed publisher

Zizzo G, De Santis M, Ferraccioli G. Mycophenolic acid in rheumatology: mechanisms of action and severe adverse events. Reumatismo. 2010;62:91-100 pubmed

Chen L, Wilson D, Xu Y, Aldrich C, Felczak K, Sham Y, et al. Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis. J Med Chem. 2010;53:4768-78 pubmed publisher

Hiemstra T, Jones R, Jayne D. Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acid. Nephron Clin Pract. 2010;116:c1-10 pubmed publisher

Cholewinski G, Malachowska Ugarte M, Dzierzbicka K. The chemistry of mycophenolic acid--synthesis and modifications towards desired biological activity. Curr Med Chem. 2010;17:1926-41 pubmed

Tonelli M, Simone M, Tasso B, Novelli F, Boido V, Sparatore F, et al. Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives. Bioorg Med Chem. 2010;18:2937-53 pubmed publisher

Kuypers D, Le Meur Y, Cantarovich M, Tredger M, Tett S, Cattaneo D, et al. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clin J Am Soc Nephrol. 2010;5:341-58 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

Stevens A, Gahan M, Mahalingam S, Keller P. The medicinal chemistry of dengue fever. J Med Chem. 2009;52:7911-26 pubmed publisher

Bruchet N, Ensom M. Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review. Expert Opin Drug Metab Toxicol. 2009;5:1079-97 pubmed publisher

Yu X, Sainz B, Uprichard S. Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening. Antimicrob Agents Chemother. 2009;53:4311-9 pubmed publisher

de Jonge H, Naesens M, Kuypers D. New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation. Ther Drug Monit. 2009;31:416-35 pubmed publisher

Tonelli M, Vazzana I, Tasso B, Boido V, Sparatore F, Fermeglia M, et al. Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives. Bioorg Med Chem. 2009;17:4425-40 pubmed publisher

Prado Prado F, Martinez de la Vega O, Uriarte E, Ubeira F, Chou K, González Díaz H. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorg Med Chem. 2009;17:569-75 pubmed publisher

Habib E, Leon F, Bauer J, Hill R, Carvalho P, Cutler H, et al. Mycophenolic derivatives from Eupenicillium parvum. J Nat Prod. 2008;71:1915-8 pubmed publisher

Santana L, González Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, et al. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008;51:6740-51 pubmed publisher

Chen L, Wilson D, Labello N, Jayaram H, Pankiewicz K. Mycophenolic acid analogs with a modified metabolic profile. Bioorg Med Chem. 2008;16:9340-5 pubmed publisher

Chen L, Petrelli R, Olesiak M, Wilson D, Labello N, Pankiewicz K. Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase. Bioorg Med Chem. 2008;16:7462-9 pubmed publisher

Oremus M, Zeidler J, Ensom M, Matsuda Abedini M, Balion C, Booker L, et al. Utility of monitoring mycophenolic acid in solid organ transplant patients. Evid Rep Technol Assess (Full Rep). 2008;:1-131 pubmed

Mezger M, Wozniok I, Blockhaus C, Kurzai O, Hebart H, Einsele H, et al. Impact of mycophenolic acid on the functionality of human polymorphonuclear neutrophils and dendritic cells during interaction with Aspergillus fumigatus. Antimicrob Agents Chemother. 2008;52:2644-6 pubmed publisher

Ryu C, Lee R, Lee S, Chung H, Lee S, Chung K. Design, synthesis and evaluation of 2-phenyl-1H-benzo[d]imidazole-4,7-diones as vascular smooth muscle cell proliferation inhibitors. Bioorg Med Chem Lett. 2008;18:2948-51 pubmed publisher

Chen L, Wilson D, Jayaram H, Pankiewicz K. Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment. J Med Chem. 2007;50:6685-91 pubmed

Chen L, Gao G, Felczak K, Bonnac L, Patterson S, Wilson D, et al. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues. J Med Chem. 2007;50:5743-51 pubmed

Moda T, Montanari C, Andricopulo A. Hologram QSAR model for the prediction of human oral bioavailability. Bioorg Med Chem. 2007;15:7738-45 pubmed

Shaw L, Figurski M, Milone M, Trofe J, Bloom R. Therapeutic drug monitoring of mycophenolic acid. Clin J Am Soc Nephrol. 2007;2:1062-72 pubmed

Ubukata M, Takamori H, Ohashi M, Mitsuhashi S, Yamashita K, Asada T, et al. Mycophenolic acid as a latent agonist of PPARgamma. Bioorg Med Chem Lett. 2007;17:4767-70 pubmed

Watterson S, Chen P, Zhao Y, Gu H, Dhar T, Xiao Z, et al. Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419). J Med Chem. 2007;50:3730-42 pubmed

Davies N, Grinyo J, Heading R, Maes B, Meier Kriesche H, Oellerich M. Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. Nephrol Dial Transplant. 2007;22:2440-8 pubmed

Elbarbry F, Shoker A. Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients. Clin Biochem. 2007;40:752-64 pubmed

de Winter B, Mathot R, van Hest R, van Gelder T. Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?. Expert Opin Drug Metab Toxicol. 2007;3:251-61 pubmed

Weimert N, Derotte M, Alloway R, Woodle E, Vinks A. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications. Ther Drug Monit. 2007;29:141-9 pubmed

Chu J, Yang P. c-Src protein kinase inhibitors block assembly and maturation of dengue virus. Proc Natl Acad Sci U S A. 2007;104:3520-5 pubmed

Stassen P, Kallenberg C, Stegeman C. Use of mycophenolic acid in non-transplant renal diseases. Nephrol Dial Transplant. 2007;22:1013-9 pubmed

Schiffer N, Broadley S, Hirschberger T, Tavan P, Kretzschmar H, Giese A, et al. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J Biol Chem. 2007;282:9195-203 pubmed

Sun Y, CHUNG D, Chu Y, Jonsson C, Parker W. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase. Antimicrob Agents Chemother. 2007;51:84-8 pubmed

Chong C, Qian D, Pan F, Wei Y, Pili R, Sullivan D, et al. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. J Med Chem. 2006;49:2677-80 pubmed

Watkins W, Chen J, Cho A, Chong L, Collins N, Fardis M, et al. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH. Bioorg Med Chem Lett. 2006;16:3479-83 pubmed

Goodell J, Puig Basagoiti F, Forshey B, Shi P, Ferguson D. Identification of compounds with anti-West Nile Virus activity. J Med Chem. 2006;49:2127-37 pubmed

Kiang T, Ensom M, Chang T. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther. 2005;106:97-132 pubmed

Gummert J, Barten M, Sherwood S, van Gelder T, Morris R. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J Pharmacol Exp Ther. 1999;291:1100-12 pubmed

Nimmesgern E, Fox T, Fleming M, Thomson J. Conformational changes and stabilization of inosine 5'-monophosphate dehydrogenase associated with ligand binding and inhibition by mycophenolic acid. J Biol Chem. 1996;271:19421-7 pubmed

Senda M, DeLustro B, Eugui E, Natsumeda Y. Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells. Transplantation. 1995;60:1143-8 pubmed